About Geneseeq
Geneseeq is a research-driven company that provides cutting-edge genomic profiling technology to accelerate precision cancer care. Our Canadian and Chinese headquarters focus on clinical genetic testing and translational research, covering all cancers and sample types.
Our Expertise
Our genomic testing services offer both pan-cancer panels analyzing 400+ genes and cancer-type specific gene panels to help match a patient to the optimal treatment, including targeted therapy and immunotherapy. Our research services providing high-quality genomic data by next-generation sequencing with fast turnaround time to accelerate translational research.
Comprehensive genetic testing
Next-generation sequencing
AI-Powered bioinformatics
Biomarker discovery
Toronto Headquarters
Headquartered in the MaRS Discovery District in Toronto since 2012, Geneseeq Canada currently employs 30+ passionate employees working in Research & Development and global business development.
Improving Patient Outcomes
Our genomic testing services offer both pan-cancer panels analyzing 400+ genes and cancer-type specific gene panels to help match a patient to the optimal treatment, including targeted therapy and immunotherapy. Our research services providing high-quality genomic data by next-generation sequencing with fast turnaround time to accelerate translational research.
Our Science
At Geneseeq, our R&D efforts in translational research play a key role in discovering novel biomarkers that are capable of guiding treatment strategies and transforming lives.
We continue to seek collaborations with both institutional and biopharma partners. To date, we have 2000+ clinical research projects and published 500+ translational research papers in peer-reviewed journals.
2000+
CLINICAL PROJECTS
in translational research
500+
PUBLICATIONS
in the past 5 years alone
Chinese Headquarters
Geneseeq’s Chinese headquarters are located in Nanjing’s High-Tech District with 1500+ staff and 10+ offices across China. The 400,000 sqft Nanjing location houses a state-of-the-art CAP/CLIA/ISO15189 accredited clinical testing center with multiple high throughput NGS platforms and an ISO13485 certified diagnostic kit manufacturing facility for NGS CDx kit production.
Our Reach
Our products and services are well established and trusted as they are ordered by 8,000+ oncologists from 800+ hospitals across China’s 25 provinces. We also engaged in 2000+ translational research projects and supported 50+ biopharmaceutical companies in their clinical trials.
8,000+
ONCOLOGISTS
ordered our genetic tests
800+
HOSPITALS
in which our products are used
250,000+
SAMPLES
testing capacity per year
50+
PARTNERS
in biopharma
JOIN OUR NEWSLETTER
LET’S ACCELERATE PRECISION CANCER CARE, TOGETHER.
Learn more about our products and services or contact us today to discuss how we can partner together.